美国心血管试验中性别与种族差异:超23万患者分析
该研究利用ClinicalTrials.gov数据评估1998至2017年间178项美国心血管试验(含CABG、瓣膜病、主动脉瘤、心室辅助装置和心脏移植)中女性及少数族裔的代表性,共237,132名参与者。结果显示女性及少数族裔(亚裔除外)参与比例偏低,CABG试验中女性、西班牙裔和非裔美国人的参与-患病率比值(PPR)均低于0.8。
要点
- 女性及少数族裔(亚裔除外)在心血管试验中代表性不足。
- CABG试验中非裔美国人PPR仅0.28,女性0.64,西班牙裔0.72。
- 2008-2012至2013-2017年间,CABG试验女性和非裔PPR下降,西班牙裔和亚裔上升。
核心结论
- 女性及少数族裔(亚裔除外)在心血管试验中的参与度仍偏低,需外科学领导、社区和产业界共同应对。
研究设计与样本
- 利用ClinicalTrials.gov公开数据,纳入1998年9月至2017年5月启动的178项美国心血管试验(159项已完成,19项活跃未招募),共237,132名参与者。
主要发现
- 全部178项试验报告了性别分布,仅76项(42.7%)报告种族分布,52项(29.2%)报告族裔分布。
- 所有试验参与者中女性占28.3%,西班牙裔/拉丁裔占11.2%,非裔美国人占4.0%,亚裔占10.4%,其他占2.3%。
- CABG试验中女性PPR为0.64,西班牙裔为0.72,非裔美国人为0.28,亚裔为3.20。
- 2008-2012至2013-2017年间,CABG试验女性PPR从0.67降至0.50,非裔美国人从0.37降至0.17,西班牙裔从0.38升至1.32,亚裔从3.51升至4.57。
关键数值与推荐
- PPR值0.8至1.2反映代表性相似。
临床怎么用
- 心胸外科医生应关注临床试验入组中的性别和种族均衡,促进少数族裔和女性患者的招募与参与。
局限性
- 仅42.7%的试验报告种族分布,29.2%报告族裔分布,数据完整性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The current representation of female patients and racial and ethnic minorities in cardiovascular trials is unclear. We evaluated these groups' inclusion in U.S. cardiovascular trials. METHODS: Using publicly available data from ClinicalTrials.gov, we evaluated cardiovascular trials pertaining to coronary artery bypass grafting (CABG), heart valve disease, aortic aneurysm, ventricular assist devices, and heart transplantation. This yielded 178 U.S. trials (159 completed, 19 active but not recruiting) started between September 1998 and May 2017, with 237,132 participants. To examine female patients' and racial and ethnic minorities' representation in these trials, we calculated participation-to-prevalence ratios (PPRs). Values of 0.8 to 1.2 reflect similar representation. RESULTS: All 178 trials reported sex distribution, whereas only 76 (42.7%) trials reported racial distribution and 52 (29.2%) trials reported ethnic (Hispanic vs non-Hispanic) distribution. Among all trials, participants were 28.3% female, 11.2% were Hispanic/Latino, 4.0% were African American, 10.4% were Asian, and 2.3% were other. The CABG PPR for female patients was 0.64, for Hispanic patients was 0.72, for African American patients was 0.28, and for Asian patients was 3.20. Between 2008-2012 and 2013-2017, the CABG PPR decreased for female patients (0.67→0.50) and African American patients (0.37→0.17) but increased for Hispanic patients (0.38→1.32) and Asian patients (3.51→4.57). CONCLUSIONS: Participation in cardiovascular trials by female patients and minorities (except Asian patients) remains low. Given that inherent differences among the previously mentioned groups could affect outcomes, balance is clearly needed. The engagement of our surgical leadership, community, and industry to address these disparities is vitally important.
引用
- Preventza O, Critsinelis A, Simpson K, et al. Sex, Racial, and Ethnic Disparities in U.S. Cardiovascular Trials in More Than 230,000 Patients. Ann Thorac Surg. 2020. PMID: 33189670. doi:10.1016/j.athoracsur.2020.08.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。